Mutant isocitrate dehydrogenase 1 (IDH1) inhibitor synergistically prolongs animal survival with standard therapies in patient-derived IDH1 mutant glioma xenograft mouse models

被引：0
|
作者：
Kogiso, Mari
Qi, Lin
Zhang, Huiyuan
Braun, Frank K.
Du, Yuchen
Huang, Yulun
Lindsay, Holly
Zhao, Sibo
Injac, Sarah G. G.
Liu, Zhen
Baxter, Patricia A.
Su, Jack M.
Perlaky, Laszlo
Parsons, D. Williams
Chintagumpala, Murali
Adesina, Adekunle
Wang, Jialiang
Song, Yongcheng
Li, Xiao-Nan
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4031
引用
收藏
页数：2
相关论文
共 50 条
  • [31] An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
    Rohle, Dan
    Popovici-Muller, Janeta
    Palaskas, Nicolaos
    Turcan, Sevin
    Grommes, Christian
    Campos, Carl
    Tsoi, Jennifer
    Clark, Owen
    Oldrini, Barbara
    Komisopoulou, Evangelia
    Kunii, Kaiko
    Pedraza, Alicia
    Schalm, Stefanie
    Silverman, Lee
    Miller, Alexandra
    Wang, Fang
    Yang, Hua
    Chen, Yue
    Kernytsky, Andrew
    Rosenblum, Marc K.
    Liu, Wei
    Biller, Scott A.
    Su, Shinsan M.
    Brennan, Cameron W.
    Chan, Timothy A.
    Graeber, Thomas G.
    Yen, Katharine E.
    Mellinghoff, Ingo K.
    SCIENCE, 2013, 340 (6132) : 626 - 630
  • [32] 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft
    Borodovsky, Alexandra
    Salmasi, Vafi
    Turcan, Sevin
    Fabius, Armida W. M.
    Baia, Gilson S.
    Eberhart, Charles G.
    Weingart, Jon D.
    Gallia, Gary L.
    Baylin, Stephen B.
    Chan, Timothy A.
    Riggins, Gregory J.
    ONCOTARGET, 2013, 4 (10) : 1737 - 1747
  • [33] Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers
    Popovici-Muller, Janeta
    Lemieux, Rene M.
    Artin, Erin
    Saunders, Jeffrey O.
    Salituro, Francesco G.
    Travins, Jeremy
    Cianchetta, Giovanni
    Cai, Zhenwei
    Zhou, Ding
    Cui, Dawei
    Chen, Ping
    Straley, Kimberly
    Tobin, Erica
    Wang, Fang
    David, Muriel D.
    Penard-Lacronique, Virginie
    Quivoron, Cyril
    Saada, Veronique
    De Botton, Stephane
    Gross, Stefan
    Dang, Lenny
    Yang, Hua
    Utley, Luke
    Chen, Yue
    Kim, Hyeryun
    Jin, Shengfang
    Gu, Zhiwei
    Yao, Gui
    Luo, Zhiyong
    Lv, Xiaobing
    Fang, Cheng
    Yan, Liping
    Olaharski, Andrew
    Silverman, Lee
    Biller, Scott
    Su, Shin-San M.
    Yen, Katharine
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (04): : 300 - 305
  • [34] IDH1 mutant inhibitor induces cellular differentiation and offers a combination benefit with Ara-C in a primary human Idh1 mutant AML xenograft model
    Ellwood-Yen, Kate
    Chen, Yue
    Wang, Fang
    Lemieux, Rene
    Popovici-Muller, Janeta
    Yang, Hua
    Straley, Kimberly
    Choe, Sung
    Dorsch, Marion
    Agresta, Sam
    Schenkein, David
    Biller, Scott
    Su, Michael
    CANCER RESEARCH, 2014, 74 (19)
  • [35] Water Networks and Correlated Motions in Mutant Isocitrate Dehydrogenase 1 (IDH1) Are Critical for Allosteric Inhibitor Binding and Activity
    Chambers, Jennifer M.
    Miller, Wade
    Quichocho, Giovanni
    Upadhye, Viraj
    Matteo, Diego Avellaneda
    Bobkov, Andrey A.
    Sohl, Christal D.
    Schiffer, Jamie M.
    BIOCHEMISTRY, 2020, 59 (04) : 479 - 490
  • [36] Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma
    Ruiz-Rodado, Victor
    Seki, Tomohiro
    Dowdy, Tyrone
    Lita, Adrian
    Zhang, Meili
    Han, Sue
    Yang, Chunzhang
    Cherukuri, Murali K.
    Gilbert, Mark R.
    Larion, Mioara
    CANCERS, 2020, 12 (06) : 1 - 12
  • [37] AG120, A FIRST-IN-CLASS MUTANT IDH1 INHIBITOR IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH1 MUTANT GLIOMA: RESULTS FROM THE PHASE 1 GLIOMA EXPANSION COHORTS
    Mellinghoff, Ingo K.
    Touat, Mehdi
    Maher, Elizabeth
    DeLaFuente, Macarena
    Cloughesy, Timothy F.
    Holdhoff, Matthias
    Cote, Gregory
    Burris, Howard
    Janku, Filip
    Huang, Raymond
    Young, Robert
    Ellingson, Benjamin
    Auer, Julia
    Liu, Hua
    Hurov, Jonathan
    Yen, Katherine
    Agresta, Sam
    Attar, Eyal
    Pandya, Susan
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2016, 18 : 12 - 12
  • [38] A vaccine targeting mutant IDH1 in newly diagnosed glioma
    Michael Platten
    Lukas Bunse
    Antje Wick
    Theresa Bunse
    Lucian Le Cornet
    Inga Harting
    Felix Sahm
    Khwab Sanghvi
    Chin Leng Tan
    Isabel Poschke
    Edward Green
    Sune Justesen
    Geoffrey A. Behrens
    Michael O. Breckwoldt
    Angelika Freitag
    Lisa-Marie Rother
    Anita Schmitt
    Oliver Schnell
    Jörg Hense
    Martin Misch
    Dietmar Krex
    Stefan Stevanovic
    Ghazaleh Tabatabai
    Joachim P. Steinbach
    Martin Bendszus
    Andreas von Deimling
    Michael Schmitt
    Wolfgang Wick
    Nature, 2021, 592 : 463 - 468
  • [39] A vaccine targeting mutant IDH1 in newly diagnosed glioma
    Platten, Michael
    Bunse, Lukas
    Wick, Antje
    Bunse, Theresa
    Le Cornet, Lucian
    Harting, Inga
    Sahm, Felix
    Sanghvi, Khwab
    Tan, Chin Leng
    Poschke, Isabel
    Green, Edward
    Justesen, Sune
    Behrens, Geoffrey A.
    Breckwoldt, Michael O.
    Freitag, Angelika
    Rother, Lisa-Marie
    Schmitt, Anita
    Schnell, Oliver
    Hense, Joerg
    Misch, Martin
    Krex, Dietmar
    Stevanovic, Stefan
    Tabatabai, Ghazaleh
    Steinbach, Joachim P.
    Bendszus, Martin
    von Deimling, Andreas
    Schmitt, Michael
    Wick, Wolfgang
    NATURE, 2021, 592 (7854) : 463 - +
  • [40] MRS BASED BIOMARKERS OF IDH1 MUTANT GLIOMA RESPONSE TO THE IDH INHIBITOR BAY-1436032
    Hong, Donghyun
    Minami, Noriaki
    Taglang, Celine
    Batsios, Georgios
    Gillespie, Anne Marie
    Pieper, Russell
    Costello, Joseph
    Viswanath, Pavithra
    Ronen, Sabrina
    NEURO-ONCOLOGY, 2021, 23 : 173 - 173
12345